Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-12-09 | New | $36,175,000 | $36,175,000 | Debt Only | 06b | SEC link |
| 2024-12-10 | New | $15,000,000 | $15,000,000 | Debt Only | 06b | SEC link |
| 2024-01-19 | New | $40,251,846 | $40,251,846 | Equity Only | 06b | SEC link |
| 2022-06-03 | New | $16,000,000 | $16,000,000 | Debt Only | 06b | SEC link |
| 2021-08-10 | New | $9,000,000 | Unknown | Equity Only | SEC link |
| Name | Role |
|---|---|
| Christine Aylward | Director |
| Jim Mellon | Director |
| Jason Pontin | Director |
| Charles Roberts | Director |
| David Roblin | Director, Executive |
| Casey Benjamin Swerner | Executive |